Effect of danshen extract on pharmacokinetics of theophylline in healthy volunteers
- 24 October 2007
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (2) , 270-274
- https://doi.org/10.1111/j.1365-2125.2007.03027.x
Abstract
Danshen extract is widely used for the treatment and prevention of coronary heart disease and other diseases of senility in Asia. Danshen extract and theophylline may be prescribed together to treat patients with asthma. In human, theophylline with low therapeutic index is mainly metabolized by CYP1A2. In vitro findings have shown that human CYP1A2 is inhibited by the ethyl acetate extract of danshen and danshen pharmaceutical product. There may be drug interactions between danshen extract and theophylline (CYP1A2 substrate). This study concerned drug interactions between danshen extract and theophylline in Chinese volunteers. Long-term oral intake of danshen extract does not change the basic pharmacokinetic parameters of theophylline. Dose adjustment of theophylline thus may not be necessary in patients receiving concomitant therapy with danshen extract. To examine the potential effect of danshen extract on the pharmacokinetics of theophylline. In a sequential cross-over study with two phases, 12 volunteers took 100 mg theophylline on day 1 and day 15. From day 2 to day 15, volunteers received danshen extract tablets three times daily, four tablets each time for 14 days. On day 15, they received four danshen extract tablets with 100 mg theophylline. Plasma concentrations of theophylline were measured on days 1 and 15 periodically for 24 h. The 90% confidence interval of C(max), t(1/2) and CL/F of theophylline with 14-day danshen extract tablets vs. without comedication were (101.42, 121.36) (84.57, 106.72) and (88.82, 105.72), respectively. The time to peak plasma theophylline concentration was unchanged by danshen (P > 0.05). The pharmacokinetics parameter of theophylline was unaffected by danshen extract. Danshen extract does not influence the metabolism of theophylline in healthy volunteers. Dose adjustment of theophylline thus may not be necessary in patients receiving concurrent therapy with danshen extract tablets.Keywords
This publication has 28 references indexed in Scilit:
- Hydrolytic kinetics of lithospermic acid B extracted from roots of Salvia miltiorrhizaJournal of Pharmaceutical and Biomedical Analysis, 2007
- Pharmacokinetics, Absorption and Tissue Distribution of Tanshinone IIA Solid DispersionPlanta Medica, 2006
- Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herbSalvia miltiorrhizaJournal of Pharmacy and Pharmacology, 2006
- Danshen: A Popular Chinese Cardiac Herbal DrugJournal of the American College of Cardiology, 2006
- Improved quality control method for Danshen products—Consideration of both hydrophilic and lipophilic active componentsJournal of Pharmaceutical and Biomedical Analysis, 2006
- Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC–MS/MS)Journal of Pharmaceutical and Biomedical Analysis, 2006
- Pharmacokinetics of Lithospermic Acid B Isolated fromSalvia Miltiorrhizain RatsJournal of Toxicology and Environmental Health, Part A, 2005
- Simultaneous determination of cryptotanshinone, tanshinone I and tanshinone IIA in traditional Chinese medicinal preparations containing Radix salvia miltiorrhiza by HPLCJournal of Pharmaceutical and Biomedical Analysis, 2005
- Study of the determination and pharmacokinetics of Compound Danshen Dripping Pills in human serum by column switching liquid chromatography electrospray ion trap mass spectrometryJournal of Chromatography B, 2004
- Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2Xenobiotica, 2003